Academic Journal
Q1International Journal of Cardiology
About International Journal of Cardiology
International Journal of Cardiology is a scholarly journal published by Elsevier Ireland Ltd. SCImago 2025 places it in Q1 with an SJR of 1.152 and an H-index of 164.
Its listed coverage is 1981-2026 and its research categories include Cardiology and Cardiovascular Medicine (Q1). The 2025 dataset reports 917 documents and 5566 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Cardiac Imaging and Diagnostics, Cardiovascular Function and Risk Factors, Coronary Interventions and Diagnostics, Atrial Fibrillation Management and Outcomes, Acute Myocardial Infarction Research, Cardiac Valve Diseases and Treatments.
Recent Research Articles
Latest publications matched automatically by ISSN.
Addressing systematic underdetection of left ventricular hypertrophy by guideline-recommended electrocardiographic criteria in women and individuals with overweight
Andreas Ohrt Johansen, Jørgen Tobias Kühl, Andreas W. Aspe, Mathias Lowes et al.
2026-12 · DOI: 10.1016/j.ijcard.2026.134761From evidence to delivery: Optimising SGLT2 inhibitor therapy in heart failure
Takahiro Jimba
2026-12 · DOI: 10.1016/j.ijcard.2026.134758Serial high-sensitivity troponin-T and risk of heart failure in individuals with suspected acute coronary syndrome
Philip Ahle Erichsen, Majid Afzal, Christina Byrne, Johanna Maria Christina Frary et al.
2026-12 · DOI: 10.1016/j.ijcard.2026.134748Intrarenal venous flow improvement after vericiguat in worsening HFrEF: indirect effect from improvements in cardiac hemodynamics or possible pleiotropic effect?
Hideaki Suzuki
2026-12 · DOI: 10.1016/j.ijcard.2026.134760Diagnostic performance of sASGR1, Cathepsin V, and the systemic immune-inflammation index for coronary vulnerable plaques: A virtual histology-intravascular ultrasound analysis
Xu Zeng, You Nie, Zeyu Zhang, Yuhua Quan et al.
2026-12 · DOI: 10.1016/j.ijcard.2026.134762Real-world mavacamten: What SWISS-MAVA adds
Roberto Licordari, Vincenzo Castiglione
2026-12 · DOI: 10.1016/j.ijcard.2026.134757Temporal changes in BNP levels and their prognostic impact on future cardiac events in patients undergoing transcatheter aortic valve implantation
Koji Mizutani, Akihito Tanaka, Yoshiyuki Tokuda, Hiroki Kondo et al.
2026-11 · DOI: 10.1016/j.ijcard.2026.134705Don't ask FFR to do what it cannot: flow limitation, not plaque instability — The risk of discrediting FFR by expecting the impossible
Ramón López-Palop, Pilar Carrillo, Íñigo Lozano
2026-11 · DOI: 10.1016/j.ijcard.2026.134756Early diagnosis following implantable loop recorder placement in patients with unexplained syncope
Morten Andreas Jørgensen, Kasper Rosenbech, Stephan Peronard Mayntz
2026-11 · DOI: 10.1016/j.ijcard.2026.134722Beyond mitral regurgitation reduction: Divergent hemodynamic and structural responses to transcatheter edge-to-edge repair in primary and secondary mitral regurgitation
Carlo Vignati, Gaia Cattadori, Fiorella Puttini, Beatrice Pezzuto et al.
2026-11 · DOI: 10.1016/j.ijcard.2026.134678Real-world effectiveness, response patterns and clinical implementation of Mavacamten in obstructive hypertrophic cardiomyopathy: Insights from the SWISS-MAVA cohort
Niccolò Maurizi, Dennis Jensen, Annina S. Vischer, Simon F. Stämpfli et al.
2026-11 · DOI: 10.1016/j.ijcard.2026.134689Tracking arterial stiffness from childhood to adolescence: the role of adiposity and cardiometabolic factors
Daniela Ventura, Sara Mosca, Ana Teixeira, Cláudia Mota et al.
2026-11 · DOI: 10.1016/j.ijcard.2026.134754Worsening heart failure and mortality in patients with transthyretin cardiac amyloidosis: The predictive role of frailty
Daniela Di Lisi, Giuseppina Novo
2026-11 · DOI: 10.1016/j.ijcard.2026.134719Electrocardiographic left ventricular hypertrophy and sudden cardiac death
Konsta Kivimäki, Leo-Pekka Lyytikäinen, Kjell Nikus, Minna Järvensivu-Koivunen et al.
2026-11 · DOI: 10.1016/j.ijcard.2026.134680Diabetes-associated diffuse myocardial fibrosis assessed by native T1 mapping: Adverse cardiac phenotype and modest incremental prognostic value in a real-world cohort
Julia M. Treiber, Sören J. Backhaus, J. Sebastian Wolter, Judith Handrick et al.
2026-11 · DOI: 10.1016/j.ijcard.2026.134730Pattern of use of conventional medical treatments of heart failure with reduced ejection fraction in end-stage hypertrophic cardiomyopathy
Giacomo Tini, Isabella Perlati, Sofia Palma, Sara Giovani et al.
2026-11 · DOI: 10.1016/j.ijcard.2026.134721Imaging signatures of high-risk arrhythmogenic genotypes in dilated cardiomyopathy
Zhigang Zhang, Yangjie Li, Yuanwei Xu, Weihao Li et al.
2026-11 · DOI: 10.1016/j.ijcard.2026.134725Clinical and procedural outcomes of IVUS-guided versus angiography-guided PCI in unprotected left main coronary disease: An updated meta-analysis of randomized controlled trials
Ahmed Emara, Ameer Awashra, Ahmed Mansour, Ahmed Adel Abdel Azim et al.
2026-11 · DOI: 10.1016/j.ijcard.2026.134755Coronary microvascular dysfunction and heart failure with preserved ventricular function: still an elusive link
Gaetano Antonio Lanza, Angelo Giuseppe Marino
2026-11 · DOI: 10.1016/j.ijcard.2026.134724PARADIGM-HF eligibility in historical German HFrEF populations: clinical characteristics and 1-year outcomes
Anastasia Janina Hobbach, Matthias Hochadel, Christiane Angermann, Stefan Störk et al.
2026-11 · DOI: 10.1016/j.ijcard.2026.134749Reviews
Community Reviews
Version History
September 8, 2026 at 12:02 am
September 8, 2026